Laure Farnault Selected Research

Laure Farnault Research Topics

8	Neoplasms (Cancer) 01/2022 - 01/2012
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2018
4	Lymphoma (Lymphomas) 08/2021 - 01/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2010
2	Multiple Myeloma 10/2019 - 01/2018
1	COVID-19 01/2022
1	Leukemia 06/2021
1	Plasmablastic Lymphoma 04/2021
1	Frailty 12/2020
1	Histiocytosis 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Hemorrhage 01/2019
1	Atrial Fibrillation 01/2019
1	Sepsis (Septicemia) 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Lymphocytosis 01/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2013
1	Cytomegalovirus Infections (Inclusion Disease) 01/2012
1	Infections 01/2012

4	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 01/2018
1	VaccinesIBA 01/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2021
1	CPX-351IBA 10/2021
1	Liposomes (Liposome)IBA 10/2021
1	Methotrexate (Mexate)FDA LinkGeneric 08/2021
1	AnthracyclinesIBA 06/2021
1	daratumumabIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020
1	C-Reactive ProteinIBA 12/2020
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2020
1	trametinibIBA 01/2020
1	blinatumomabIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019
1	Lenalidomide (CC 5013)FDA Link 10/2019
1	Bortezomib (Velcade)FDA Link 10/2019
1	purineIBA 09/2019
1	AnticoagulantsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	ibrutinibIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	Histocompatibility Antigens Class IIBA 12/2013
1	Janus KinasesIBA 04/2013
1	PerforinIBA 01/2012
1	thymoglobulin FDA Link 12/2010
1	Busulfan (Busulfex)FDA Link 12/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010

5	Therapeutics 06/2021 - 01/2012
3	Stem Cell Transplantation 12/2013 - 12/2010
2	Transplantation 10/2019 - 01/2012
1	Activities of Daily Living (ADL) 01/2022
1	Renal Dialysis (Hemodialysis) 08/2021
1	Immunotherapy 06/2021
1	Ambulatory Care (Outpatient Care) 12/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Drug Therapy (Chemotherapy) 01/2018